speb/financial-data huggingface dataset:
IBRX income_statement (annual, 2025-12-31) — +Total Revenue: 113288000.00
IBRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 38285000.00
IBRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 6978000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 6978000.00
IBRX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 42571000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 42571000.00
IBRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -112485000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -112485000.00
IBRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3197120000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3197120000.00
IBRX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -2745000.00
IBRX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -1704000.00
IBRX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 14018000.00
IBRX income_statement (annual, 2025-12-31) — Basic Average Shares: 919863000.00
IBRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 989679000.00
IBRX income_statement (annual, 2025-12-31) — Basic EPS: -0.38
IBRX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.06
IBRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 143912000.00
IBRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 61337000.00
IBRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -4252000.00
IBRX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1275000.00
IBRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 40982000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 40982000.00
IBRX balance_sheet (annual, 2025-12-31) — Capital Stock: 101000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 101000.00
IBRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 88334000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 88334000.00
IBRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 242818000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 242818000.00
IBRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 400241000.00
IBRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 54894000.00
IBRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -149801000.00
IBRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 43573000.00
IBRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -304936000.00
IBRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -70378000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -190000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 979000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 3184000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1925000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Inventory: -6325000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -7894000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 803000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -16000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -7210000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1841000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 477000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -68000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Payable: -190000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Payable: 979000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2994000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2904000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -4857000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3062000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Receivables: -40211000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -10555000.00
IBRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -54329000.00
IBRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -14408000.00
IBRX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -40211000.00
IBRX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -10555000.00
IBRX cash_flow (annual, 2025-12-31) — Changes In Cash: -54496000.00
IBRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 28089000.00
IBRX balance_sheet (annual, 2025-12-31) — Common Stock: 101000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 101000.00
IBRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -500469000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -500469000.00
IBRX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 400562000.00
IBRX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 53744000.00
IBRX balance_sheet (annual, 2025-12-31) — Construction In Progress: 86433000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 86433000.00
IBRX income_statement (annual, 2025-12-31) — Cost Of Revenue: 753000.00
IBRX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 382000.00
IBRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 23697000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 23697000.00
IBRX balance_sheet (annual, 2025-12-31) — Current Assets: 314875000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 314875000.00
IBRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 7535000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 7535000.00
IBRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 7535000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 7535000.00
IBRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 61754000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 61754000.00
IBRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 15525000.00
IBRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3865000.00
IBRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 15525000.00
IBRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3865000.00
IBRX balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 104139000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 104139000.00
IBRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 919863000.00
IBRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 989679000.00
IBRX income_statement (annual, 2025-12-31) — Diluted EPS: -0.38
IBRX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.06
IBRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -351398000.00
IBRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -61944000.00
IBRX balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 46000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 46000.00
IBRX balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 403000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 403000.00
IBRX income_statement (annual, 2025-12-31) — EBIT: -239082000.00
IBRX income_statement (quarterly, 2025-12-31) — EBIT: -34901000.00
IBRX income_statement (annual, 2025-12-31) — EBITDA: -223557000.00
IBRX income_statement (quarterly, 2025-12-31) — EBITDA: -31036000.00
IBRX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 0.00
IBRX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 15000.00
IBRX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 5000.00
IBRX cash_flow (annual, 2025-12-31) — End Cash Position: 89431000.00
IBRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 89431000.00
IBRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 400241000.00
IBRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 54894000.00
IBRX cash_flow (annual, 2025-12-31) — Free Cash Flow: -309188000.00
IBRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -71653000.00
IBRX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -53320000.00
IBRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -27176000.00
IBRX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 59203000.00
IBRX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 31062000.00
IBRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 28956000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 28956000.00
IBRX balance_sheet (annual, 2025-12-31) — Goodwill: 910000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Goodwill: 910000.00
IBRX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 13953000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 13953000.00
IBRX balance_sheet (annual, 2025-12-31) — Gross PPE: 259759000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 259759000.00
IBRX income_statement (annual, 2025-12-31) — Gross Profit: 112535000.00
IBRX income_statement (quarterly, 2025-12-31) — Gross Profit: 37903000.00
IBRX income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
IBRX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
IBRX cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
IBRX income_statement (annual, 2025-12-31) — Interest Expense: 112525000.00
IBRX income_statement (quarterly, 2025-12-31) — Interest Expense: 27192000.00
IBRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 112525000.00
IBRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 27192000.00
IBRX income_statement (annual, 2025-12-31) — Interest Income: 2689000.00
IBRX income_statement (quarterly, 2025-12-31) — Interest Income: 579000.00
IBRX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2689000.00
IBRX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 579000.00
IBRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 71321000.00
IBRX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 18589000.00
IBRX balance_sheet (annual, 2025-12-31) — Inventory: 910000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Inventory: 910000.00
IBRX balance_sheet (annual, 2025-12-31) — Invested Capital: -23376000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: -23376000.00
IBRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -149801000.00
IBRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 43573000.00
IBRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 400562000.00
IBRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 53744000.00
IBRX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2884000.00
IBRX balance_sheet (annual, 2025-12-31) — Leases: 73141000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Leases: 73141000.00
IBRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 33447000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 33447000.00
IBRX balance_sheet (annual, 2025-12-31) — Long Term Debt: 477093000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 477093000.00
IBRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 510540000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 510540000.00
IBRX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
IBRX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -28000.00
IBRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -12000.00
IBRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3916000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3916000.00
IBRX balance_sheet (annual, 2025-12-31) — Minority Interest: 895000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Minority Interest: 895000.00
IBRX income_statement (annual, 2025-12-31) — Minority Interests: 74000.00
IBRX income_statement (quarterly, 2025-12-31) — Minority Interests: 14000.00
IBRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 400562000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 53744000.00
IBRX balance_sheet (annual, 2025-12-31) — Net Debt: 388759000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Net Debt: 388759000.00
IBRX income_statement (annual, 2025-12-31) — Net Income: -351398000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income: -61944000.00
IBRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -351398000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -61944000.00
IBRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -351472000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -61958000.00
IBRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -351398000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -61944000.00
IBRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -351398000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -61944000.00
IBRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -351472000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -61958000.00
IBRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -351472000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -61958000.00
IBRX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -406000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -372000.00
IBRX income_statement (annual, 2025-12-31) — Net Interest Income: -109836000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Interest Income: -26613000.00
IBRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -145549000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 44848000.00
IBRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2856000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2872000.00
IBRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -28000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -12000.00
IBRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -109836000.00
IBRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -26613000.00
IBRX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1132000.00
IBRX balance_sheet (annual, 2025-12-31) — Net PPE: 147274000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 147274000.00
IBRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3846000.00
IBRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -903000.00
IBRX cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2884000.00
IBRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -514422000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -514422000.00
IBRX balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 7380000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 7380000.00
IBRX income_statement (annual, 2025-12-31) — Normalized EBITDA: -282760000.00
IBRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -62098000.00
IBRX income_statement (annual, 2025-12-31) — Normalized Income: -410601000.00
IBRX income_statement (quarterly, 2025-12-31) — Normalized Income: -92938466.30
IBRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -304936000.00
IBRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -70378000.00
IBRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -53320000.00
IBRX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -27176000.00
IBRX income_statement (annual, 2025-12-31) — Operating Income: -256027000.00
IBRX income_statement (quarterly, 2025-12-31) — Operating Income: -64683000.00
IBRX income_statement (annual, 2025-12-31) — Operating Revenue: 112982000.00
IBRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 38272000.00
IBRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1011800008.00
IBRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1011800008.00
IBRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 2135000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2135000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 3073000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3073000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 28956000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 28956000.00
IBRX income_statement (annual, 2025-12-31) — Other Income Expense: 14256000.00
IBRX income_statement (quarterly, 2025-12-31) — Other Income Expense: 29203000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 13043000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 13043000.00
IBRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 90578000.00
IBRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8239000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 18416000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 18416000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 325039000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 325039000.00
IBRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -44947000.00
IBRX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1859000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Properties: 96269000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 96269000.00
IBRX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 154484000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 154484000.00
IBRX balance_sheet (annual, 2025-12-31) — Payables: 7381000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Payables: 7381000.00
IBRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 31078000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 31078000.00
IBRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 20068000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 20068000.00
IBRX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 26395000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 26395000.00
IBRX income_statement (annual, 2025-12-31) — Pretax Income: -351607000.00
IBRX income_statement (quarterly, 2025-12-31) — Pretax Income: -62093000.00
IBRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -2045000.00
IBRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -590000.00
IBRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
IBRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IBRX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -406000.00
IBRX cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -372000.00
IBRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -241373000.00
IBRX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -45626000.00
IBRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3846000.00
IBRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -903000.00
IBRX balance_sheet (annual, 2025-12-31) — Receivables: 42617000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Receivables: 42617000.00
IBRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 753000.00
IBRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 382000.00
IBRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 15525000.00
IBRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3865000.00
IBRX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -28000.00
IBRX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -12000.00
IBRX income_statement (annual, 2025-12-31) — Research And Development: 218559000.00
IBRX income_statement (quarterly, 2025-12-31) — Research And Development: 63857000.00
IBRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -3726646000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -3726646000.00
IBRX cash_flow (annual, 2025-12-31) — Sale Of Investment: 95824000.00
IBRX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 90474000.00
IBRX income_statement (annual, 2025-12-31) — Selling General And Administration: 150003000.00
IBRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 38729000.00
IBRX balance_sheet (annual, 2025-12-31) — Share Issued: 1011963808.00
IBRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 1011963808.00
IBRX cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 2884000.00
IBRX income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
IBRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 36809000.00
IBRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8746000.00
IBRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: -500469000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -500469000.00
IBRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: -514422000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -514422000.00
IBRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IBRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 67533.70
IBRX income_statement (annual, 2025-12-31) — Tax Provision: -135000.00
IBRX income_statement (quarterly, 2025-12-31) — Tax Provision: -135000.00
IBRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IBRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IBRX balance_sheet (annual, 2025-12-31) — Total Assets: 501898000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 501898000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Capitalization: -23376000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -23376000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Debt: 518075000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 518075000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -499574000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -499574000.00
IBRX income_statement (annual, 2025-12-31) — Total Expenses: 369315000.00
IBRX income_statement (quarterly, 2025-12-31) — Total Expenses: 102968000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1001472000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1001472000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 187023000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 187023000.00
IBRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 939718000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 939718000.00
IBRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -256027000.00
IBRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -64683000.00
IBRX income_statement (annual, 2025-12-31) — Total Unusual Items: 59203000.00
IBRX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 31062000.00
IBRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 59203000.00
IBRX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 31062000.00
IBRX balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 163800.00
IBRX balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
IBRX cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
IBRX balance_sheet (annual, 2025-12-31) — Working Capital: 253121000.00
IBRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 253121000.00
IBRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 113759000.00
IBRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 44206000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11192000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 43271000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -115745000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3461865000.00
IBRX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -1526000.00
IBRX cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 7442000.00
IBRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1026874000.00
IBRX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.62
IBRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 89431000.00
IBRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1787000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 40773000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 104000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 205194000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 380879000.00
IBRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 223926000.00
IBRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -31650000.00
IBRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -75359000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 3901000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 3137000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -4985000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1052000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1930000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 570000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Payable: 3901000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 7038000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 559000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -700000.00
IBRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -500000.00
IBRX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -700000.00
IBRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 116917000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 104000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -870006000.00
IBRX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 102227000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 86433000.00
IBRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 238000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 34493000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 452953000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 7626000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 7626000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 67952000.00
IBRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 4380000.00
IBRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 4380000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 331507000.00
IBRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1026874000.00
IBRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.62
IBRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -632782000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 3000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 930000.00
IBRX income_statement (quarterly, 2026-03-31) — EBIT: -604324000.00
IBRX income_statement (quarterly, 2026-03-31) — EBITDA: -599944000.00
IBRX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 122000.00
IBRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 206470000.00
IBRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 223926000.00
IBRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -77146000.00
IBRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 292880000.00
IBRX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -292727000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 27453000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Goodwill: 910000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12885000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 261564000.00
IBRX income_statement (quarterly, 2026-03-31) — Gross Profit: 43968000.00
IBRX income_statement (quarterly, 2026-03-31) — Interest Expense: 28464000.00
IBRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 28464000.00
IBRX income_statement (quarterly, 2026-03-31) — Interest Income: 736000.00
IBRX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 736000.00
IBRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 20115000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Inventory: 547000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: -191620000.00
IBRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -31650000.00
IBRX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 102227000.00
IBRX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 61000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Leases: 73277000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 33147000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 678386000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 711533000.00
IBRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 61000.00
IBRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -13000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3968000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Minority Interest: 880000.00
IBRX income_statement (quarterly, 2026-03-31) — Minority Interests: 15000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 102227000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Net Debt: 473192000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income: -632782000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -632782000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -632797000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -632782000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -632782000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -632797000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -632797000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -11000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Interest Income: -27728000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -29863000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 48000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 48000.00
IBRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -27728000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 74132000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 145819000.00
IBRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1776000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -882891000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 0.00
IBRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -307217000.00
IBRX income_statement (quarterly, 2026-03-31) — Normalized Income: -457145800.00
IBRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -75359000.00
IBRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 292880000.00
IBRX income_statement (quarterly, 2026-03-31) — Operating Income: -69791000.00
IBRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 44167000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1047341146.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3023000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2450000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 27453000.00
IBRX income_statement (quarterly, 2026-03-31) — Other Income Expense: -535269000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 11975000.00
IBRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 9968000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 34980000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 404771000.00
IBRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -242542000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 97886000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 175685000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Payables: 12122000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 46615000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11261000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 25230000.00
IBRX income_statement (quarterly, 2026-03-31) — Pretax Income: -632788000.00
IBRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 47519000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
IBRX cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -11000.00
IBRX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -149093000.00
IBRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1776000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Receivables: 43274000.00
IBRX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 238000.00
IBRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 4380000.00
IBRX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -13000.00
IBRX income_statement (quarterly, 2026-03-31) — Research And Development: 67989000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -4359428000.00
IBRX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 119230000.00
IBRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 45770000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 1047504946.00
IBRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8169000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -870006000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -882891000.00
IBRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -117090800.00
IBRX income_statement (quarterly, 2026-03-31) — Tax Provision: 9000.00
IBRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
IBRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 646637000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -191620000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 719159000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -869126000.00
IBRX income_statement (quarterly, 2026-03-31) — Total Expenses: 113997000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1515763000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 193684000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1447811000.00
IBRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -69791000.00
IBRX income_statement (quarterly, 2026-03-31) — Total Unusual Items: -292727000.00
IBRX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -292727000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 236625000.00
IBRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 385001000.00
IBS.LS balance_sheet (annual, 2021-12-31) — Cash Equivalents: 95938791.00
IBS.LS balance_sheet (annual, 2021-12-31) — Cash Financial: 1029212.00
IBS.LS cash_flow (annual, 2021-12-31) — Common Stock Issuance: 39578472.00
IBS.LS balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 18976.00
IBS.LS balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 841165.00
IBS.LS balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 303656.00
IBS.LS balance_sheet (annual, 2021-12-31) — Investmentsin Joint Venturesat Cost: 2636662.00
IBS.LS cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 39578472.00
IBS.LS balance_sheet (annual, 2021-12-31) — Net Debt: 73201896.00
IBS.LS balance_sheet (annual, 2021-12-31) — Other Current Assets: 5803060.00
IBS.LS balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 8480036.00
IBS.LS balance_sheet (annual, 2021-12-31) — Other Non Current Assets: -6.00
IBS.LS balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 4176.00
IBS.LS income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 61354936.00
IBS.LS balance_sheet (annual, 2021-12-31) — Tangible Book Value: 113669577.00
IBS.LS income_statement (annual, 2022-12-31) — +Operating Expense: 150106500.00
IBS.LS income_statement (annual, 2022-12-31) — +Total Revenue: 355596569.00
IBS.LS balance_sheet (annual, 2022-12-31) — Accounts Payable: 60214442.00
IBS.LS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 14811261.00
IBS.LS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -214803767.00
IBS.LS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2631414.00
IBS.LS balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 5428897.00
IBS.LS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2477133.00
IBS.LS income_statement (annual, 2022-12-31) — Basic Average Shares: 38264349.00
IBS.LS income_statement (annual, 2022-12-31) — Basic EPS: 4.18
IBS.LS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 96968003.00
IBS.LS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 202445206.00
IBS.LS cash_flow (annual, 2022-12-31) — Capital Expenditure: -43275747.00
IBS.LS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 90873709.00
IBS.LS balance_sheet (annual, 2022-12-31) — Capital Stock: 46000000.00
IBS.LS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 231702900.00
IBS.LS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 232294625.00
IBS.LS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -5724003.00
IBS.LS cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: 112422126.00
IBS.LS cash_flow (annual, 2022-12-31) — Changes In Cash: 139517923.00
IBS.LS cash_flow (annual, 2022-12-31) — Classesof Cash Payments: -407123032.00
IBS.LS cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: 522059661.00
IBS.LS balance_sheet (annual, 2022-12-31) — Common Stock: 46000000.00
IBS.LS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 383775279.00
IBS.LS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
IBS.LS cash_flow (annual, 2022-12-31) — Common Stock Payments: -229711.00
IBS.LS balance_sheet (annual, 2022-12-31) — Construction In Progress: 1406440.00
IBS.LS income_statement (annual, 2022-12-31) — Cost Of Revenue: 183225980.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Assets: 312167247.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 20760371.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Debt: 23847026.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 44607397.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 1526337.00
IBS.LS balance_sheet (annual, 2022-12-31) — Current Liabilities: 145722650.00
IBS.LS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 39061832.00
IBS.LS income_statement (annual, 2022-12-31) — Depreciation Income Statement: 39061832.00
IBS.LS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
IBS.LS income_statement (annual, 2022-12-31) — Diluted Average Shares: 38264349.00
IBS.LS income_statement (annual, 2022-12-31) — Diluted EPS: 4.18
IBS.LS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 159875149.00
IBS.LS income_statement (annual, 2022-12-31) — EBIT: 21651962.00
IBS.LS income_statement (annual, 2022-12-31) — EBITDA: 60713794.00
IBS.LS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 422816.00
IBS.LS cash_flow (annual, 2022-12-31) — End Cash Position: 237132629.00
IBS.LS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -123848944.00
IBS.LS balance_sheet (annual, 2022-12-31) — Finished Goods: 486703.00
IBS.LS cash_flow (annual, 2022-12-31) — Free Cash Flow: 69146379.00
IBS.LS income_statement (annual, 2022-12-31) — General And Administrative Expense: 4444036.00
IBS.LS balance_sheet (annual, 2022-12-31) — Goodwill: 54391775.00
IBS.LS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 81254558.00
IBS.LS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 17442675.00
IBS.LS balance_sheet (annual, 2022-12-31) — Gross PPE: 435271746.00
IBS.LS income_statement (annual, 2022-12-31) — Gross Profit: 172370589.00
IBS.LS balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 2477133.00
IBS.LS income_statement (annual, 2022-12-31) — Interest Expense: 7098954.00
IBS.LS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 7098954.00
IBS.LS income_statement (annual, 2022-12-31) — Interest Income: 1443289.00
IBS.LS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1443289.00
IBS.LS cash_flow (annual, 2022-12-31) — Interest Paid Cff: -13150460.00
IBS.LS cash_flow (annual, 2022-12-31) — Interest Received Cfi: 1693147.00
IBS.LS balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -74981.00
IBS.LS balance_sheet (annual, 2022-12-31) — Inventory: 13084136.00
IBS.LS balance_sheet (annual, 2022-12-31) — Invested Capital: 453857165.00
IBS.LS cash_flow (annual, 2022-12-31) — Investing Cash Flow: 150944741.00
IBS.LS balance_sheet (annual, 2022-12-31) — Investment Properties: 8470400.00
IBS.LS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2477133.00
IBS.LS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
IBS.LS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 3000000.00
IBS.LS balance_sheet (annual, 2022-12-31) — Land And Improvements: 15037941.00
IBS.LS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 70113338.00
IBS.LS balance_sheet (annual, 2022-12-31) — Long Term Debt: 46234860.00
IBS.LS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 116348198.00
IBS.LS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 3000000.00
IBS.LS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -83427754.00
IBS.LS balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 3087921.00
IBS.LS balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2530869.00
IBS.LS balance_sheet (annual, 2022-12-31) — Minority Interest: -81719.00
IBS.LS income_statement (annual, 2022-12-31) — Minority Interests: 1956.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -229711.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income: 159875149.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 159875149.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 16694734.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 143178459.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 159875149.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 16696690.00
IBS.LS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 159873193.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -3682205.00
IBS.LS income_statement (annual, 2022-12-31) — Net Interest Income: -7665283.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1298593.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -80427754.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -80427754.00
IBS.LS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -7665283.00
IBS.LS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 193822250.00
IBS.LS balance_sheet (annual, 2022-12-31) — Net PPE: 220467979.00
IBS.LS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -39589858.00
IBS.LS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 302520721.00
IBS.LS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 9989258.00
IBS.LS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4303563.00
IBS.LS income_statement (annual, 2022-12-31) — Normalized EBITDA: 60952087.00
IBS.LS income_statement (annual, 2022-12-31) — Normalized Income: 16884941.47
IBS.LS income_statement (annual, 2022-12-31) — Operating Income: 22264089.00
IBS.LS income_statement (annual, 2022-12-31) — Operating Revenue: 355596569.00
IBS.LS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 38229350.00
IBS.LS cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 223887.00
IBS.LS cash_flow (annual, 2022-12-31) — Other Cash Paymentsfrom Operating Activities: -16895137.00
IBS.LS balance_sheet (annual, 2022-12-31) — Other Current Assets: 3041134.00
IBS.LS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 8401652.00